Dominic Marasco - 23 Jun 2025 Form 4 Insider Report for MANNKIND CORP (MNKD)

Role
Pres, Endocrine Business Unit
Signature
/s/ Dominic Marasco
Issuer symbol
MNKD
Transactions as of
23 Jun 2025
Net transactions value
$0
Form type
4
Filing time
25 Jun 2025, 21:00:08 UTC
Previous filing
16 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Marasco Dominic Pres, Endocrine Business Unit 1 CASPER STREET, DANBURY /s/ Dominic Marasco 25 Jun 2025 0002053897

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNKD Performance Restricted Stock Unit Award $0 +1,000,000 $0.000000 1,000,000 23 Jun 2025 Common Stock, $0.01 Par Value 1,000,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
F2 The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%.